Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

Comparison of changes in bone density and turnover with abacavir-lamivudine versus tenofovir-emtricitabine in HIV-infected adults: 48-week results from the ASSERT study

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. All-cause mortality due to bacteraemia during a 60-day non-physician healthcare worker strike

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Dabigatran and The Risk of Staphylococcus Aureus Bacteremia- A Nationwide Cohort Study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. HIV infection is associated with type 2 diabetes mellitus

    Publikation: Bidrag til tidsskriftLetterForskningpeer review

  2. De novo electrocardiographic abnormalities in persons living with HIV

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. HIV infection is associated with thoracic and abdominal aortic aneurysms: a prospective matched cohort study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Hans-Jürgen Stellbrink
  • Chloe Orkin
  • Jose Ramon Arribas
  • Juliet Compston
  • Jan Gerstoft
  • Eric Van Wijngaerden
  • Adriano Lazzarin
  • Giuliano Rizzardini
  • Herman G Sprenger
  • John D. C. Lambert
  • Gunta Sture
  • David Leather
  • Sara Hughes
  • Patrizia Zucchi
  • Helen Pearce
  • ASSERT Study Group
Vis graf over relationer
Abacavir-lamivudine and tenofovir DF-emtricitabine fixed-dose combinations are commonly used as first-line antiretroviral therapies. However, few studies have comprehensively compared their relative safety profiles.
OriginalsprogEngelsk
TidsskriftClinical infectious diseases : an official publication of the Infectious Diseases Society of America
Vol/bind51
Udgave nummer8
Sider (fra-til)963-72
Antal sider10
DOI
StatusUdgivet - 15 okt. 2010

ID: 32217762